Comparing two diets for children with Crohn's disease
Part of Digestive system clinical trials.
This trial tests whether a Nordic-adapted version of a special diet (called CDED) works as well as the standard version for children with Crohn's disease. It aims to help reduce inflammation and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 18 years old
- You have been diagnosed with Crohn's disease within the last 3 years
- You have signs of active inflammation (like high CRP, ESR, or fecal calprotectin)
- You are not currently taking steroids
- You do not have other conditions like diabetes, celiac disease, or an eating disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cells in the intestine process waste (a process called autophagy) in children with Crohn's disease. It aims to better understand the disease and may lead to better treatments in the future.
This study tests whether a specific “exclusion diet” (removing certain foods) added to standard treatment can better control unstable Crohn’s disease in children. It may help reduce inflammation and flare-ups when symptoms are not controlled by usual medicines.
This study tests whether a specially designed anti-inflammatory American diet can help control mild to moderate Crohn's Disease symptoms. Participants will follow a diet plan, with guidance from the research team, to see if it reduces inflammation and improves quality of life.
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
This study tests if a special diet (called CDED) combined with infliximab (a biologic drug) is more effective than infliximab alone for children with newly diagnosed or relapsed moderate-to-severe Crohn’s disease. It aims to improve gut healing and reduce inflammation.
This study tests whether adding a special diet (called CDED) to a biologic medicine (infliximab or adalimumab) helps control Crohn's disease better than the medicine alone. It may reduce inflammation and improve symptoms.
Hear when a new Pediatric Crohns Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.